Ghent University Academic Bibliography

1 – 8 of 8

show: 10
|
sort: year (new to old)

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://biblio.ugent.be/publication?embed=1&q=parent+exact+%22NEURO-ONCOLOGY%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1&amp;hide_cluster=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

Email this snippet

2017
- C3
- conference
In vitro and in vivo evaluation of the LAT1 PET tracer 2-[18F]FELP in comparison to [18F]FET and [18F]FDG
Jeroen Verhoeven UGent, Julie Bolcaen, Ken Kersemans, Valerie De Meulenaere UGent, Benedicte Descamps UGent, Jean-Pierre Kalala Okito UGent, Caroline Van den Broecke UGent, Karel Deblaere UGent, Christian Vanhove UGent, Ingeborg Goethals UGent, et al. (2017) NEURO-ONCOLOGY. 19(suppl. 3). p.46-46 Mark
2016
- C3
- conference
Automated grade prediction of glioma patients based on magnetic resonance imaging and a random forests approach
Stijn Bonte UGent, Ingeborg Goethals UGent and Roel Van Holen UGent (2016) Neuro-Oncology. 18(Supplement 4). p.iv38-iv38 Mark
2014
- C3
- conference
Use of 18F-fluoromethylcholine PET in early treatment response assessment in glioblastoma patients
Julie Bolcaen, Marjan Acou UGent, Tom Boterberg UGent, Karel Deblaere UGent, F De Vos, GIORGIO HALLAERT, Jean-Pierre Kalala Okito UGent and C Van den Broecke (2014) NEURO-ONCOLOGY. 16(suppl. 2). Mark
- C3
- conference
Combination of gene copy gain and epigenetic deregulation are associated with the aberrant expression of a stem cell related HOX-signature in glioblastoma
Sebastian Kurscheid, Pierre Bady, Davide Sciuscio, Ivana Samarzija, Tal Shay, Irene Vassallo, Wim Van Criekinge UGent, Eytan Domany, Roger Stupp, Mauro Delorenzi, et al. (2014) NEURO-ONCOLOGY. 16(suppl. 5). Mark
2012
- A1
- journalArticle
Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas
Annette Künkele, Katleen De Preter UGent, Lukas Heukamp, Theresa Thor, Kristian W Pajtler, Wolfgang Hartmann, Michel Mittelbronn, Michael A Grotzer, Hedwig E Deubzer, Franki Speleman UGent, et al. (2012) NEURO-ONCOLOGY. 14(7). p.859-869 Mark
2010
- C3
- conference
Safety analysis of randomized Belgian phase II trial of extended use of adjuvant temozolomide in newly diagnosed glioblastoma patients
L Renard, PM Clement, F Hammouch, Tom Boterberg UGent, V Verschaeve, N Whenham, C Mitine, D Devriendt and J Baurain (2010) NEURO-ONCOLOGY. 12(Suppl. 3). p.46-47 Mark
- C3
- conference
Unusual imaging findings in a temporal lobe high-grade glioma with involvement of brainstem white matter tracts
MC Hoeberigs, S Meens-Koreman, PAM Hofman, OEMG Schijns, David Creytens UGent and AA Postma (2010) NEURO-ONCOLOGY. 12(suppl. 3). p.iii37-iii37 Mark
- C3
- conference
Treatment and decision-making at the end of life of high-grade glioma patients
Eefje M Sizoo, H Roeline W Pasman, Jaap C Reijneveld, Jan J Heimans, Luc Deliens UGent and Martin J Taphoorn (2010) NEURO-ONCOLOGY. 12(suppl. 4). p.100-100 Mark

your query:: Remove parent exact "NEURO-ONCOLOGY"